Logo

Caris

Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment

The pharma firm is using Caris’ comprehensive molecular profiling to help advance its investigational Porcupine inhibitor, RXC004, in the US.

In Brief This Week: AstraZeneca, CytoDyn, BerGenBio, Bayer, Dana-Farber Cancer Institute, Kronos Bio

News items for the week of Nov 8, 2021.

In Brief This Week: LUNGevity Foundation, Caris Life Sciences, Deep Lens, Genetic Technologies

News items for the week of Oct. 25, 2021. 

Caris Life Sciences, Ono Pharmaceutical Ink Cancer Drug Development Collaboration

The pharma firm will use Caris' comprehensive sequencing services, including its liquid biopsy assay, to advance development of targeted and immuno-oncology drugs.

Caris Life Sciences, Essa Pharma Ink Liquid Biopsy Partnership for Prostate Cancer Trial

Essa will use Caris' blood-based sequencing tests to assess the genetic profiles of mCRPC patients enrolled in a Phase I trial of the firm's investigational agent.

Aug 27, 2021

In Brief This Week: Roche, Immunocore, OrigiMed, Mount Sinai, Caris Life Sciences, CellMax Life

Jun 15, 2021

Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development

Jun 2, 2021

Rain Therapeutics Partners With Caris to Enroll Patients for MDM2 Inhibitor Basket Trial

May 19, 2021

Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing
Premium

May 14, 2021

In Brief This Week: Merck, Sidney Kimmel Cancer Center, Seattle Cancer Care Alliance

Apr 9, 2021

In Brief This Week: Gilead Sciences, Atossa Therapeutics, Karmanos Cancer Institute

Mar 26, 2021

In Brief This Week: Mirati Therapeutics, Gilead, Natera, Actinium Pharmaceuticals, Myriad Genetics

Mar 23, 2021

Caris-Led Team Searches for Clues to Poor COVID-19 Outcomes in Cancer Patients' Transcriptome Data
Premium

Mar 12, 2021

In Brief This Week: FDA, Inivata, Allegheny Health Network Cancer Institute, NEC Corporation

Feb 19, 2021

In Brief This Week: AstraZeneca, Merck, Amgen, Kintara Therapeutics, Dana Farber Cancer Institute

Jan 22, 2021

Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit
Premium

Jan 5, 2021

Precision Oncology in 2020: Pandemic Lessons, Biomarker Controversies, Community Access Gaps
Premium

Dec 9, 2020

Caris Shares Full Chemo Personalization Assay Data for Colon Cancer; Plans for Other Tumor Types
Premium

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 17, 2020

Reinsurer SCOR Offering Cancer Genomic Testing as Benefit for Policyholders, Life Insurance Clients
Premium

Oct 27, 2020

Caris Life Sciences Raises $310M Through Equity, Debt Financing

Aug 11, 2020

Caris Life Sciences, Elevation Oncology Partner on Patient Enrollment for Tumor-Agnostic Drug Trial

Jul 14, 2020

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

May 7, 2020

Caris Life Sciences' MI FOLFOXai Predictor Brings Precision to Colorectal Cancer Chemo Decisions
Premium

Apr 28, 2020

Caris Life Sciences Seeks FDA Approval for Exome, Transcriptome CDx Assays